Singapore magazine | Health | Beauty | medical | Female | men | wellness | Article | News

First-in-Human Trial of Cancer Vaccine

Medical kitNational Cancer Centre Singapore (NCCS) has commenced a trial for a new cancer vaccine – the first trial in the world to be administered to human patients. Led by one of NCCS’s top clinician scientists, the Phase I clinical trial also scores another first for Singapore as it is endorsed by both US Food and Drug Administration (FDA) and Singapore’s Health Sciences Authority (HSA). The trial is sponsored by Singapore Clinical Research Institute (SCRI).

This cancer vaccine, developed in the US by a biotech company, is a form of cancer immunotherapy that can enhance and boost the body’s immune cells to attack a target protein in cancer cells. Cancer immunotherapy has emerged as one of the most exciting medical breakthroughs in the past two years.

Patients who underwent the trial are doing well. They suffer from breast and ovarian cancers. One is a foreign patient who flies here regularly to be on the trial.

Posted by ezyhealth on Mar 6 2015. Filed under Health Radar. You can follow any responses to this entry through the RSS 2.0. Both comments and pings are currently closed.

Copyright © 2018 All rights reserved.Reproduction or redistribution of any content and images, is prohibited without the prior written consent of Ezyhealth Media Pte Ltd.
Health Magazine | Doctor Magazine | Medical Magazine | Beauty Magazine | Magazine Promotion
php developer india